Sigley v. Teva Pharmaceuticals, USA, Inc. et al
| Ashley Sigley |
| TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, CooperSurgial, Inc. and The Cooper Companies Inc |
| 1:2021cv01362 |
| April 5, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 5, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 33
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
|
Filing 32
ELEVENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 3/09/21. (aar)
|
| Filing 31 Case transferred in from District of West Virginia Northern; Case Number 1:20-cv-00257. Original file certified copy of transfer order and docket sheet received. |
| Filing 30 CERTIFIED COPY OF JPML TRANSFER ORDER MDL No. 2974. This case has been transferred to the Northern District of Georgia. Transferred to Judge Leigh Martin May, pursuant to MDL transfer order (MDL 2974). Signed by Karen K. Caldwell, Chair. (njz) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 29 NOTICE by CooperSurgial, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. of Transfer by the Judicial Panel on Multidistrict Litigation to the Northern District of Georgia (Attachments: #1 Exhibit 1)(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Clerk's Certificate of Mailing as to John D. Hurst, Jacob R. Stout, Wm. Scott Wickline, Christopher D. Pence, James P. McHugh, and Chelsea Lane Monroe re #33 Order. (tmf) |
| Civil Case Terminated. (tmf) |
| Case transferred to Northern District of Georgia re: MDL No. 2974. Entire Case file electronically transmitted. (njz) [Transferred from West Virginia Northern on 4/5/2021.] |
|
Filing 28
ORDER granting Chelsea L. Monroe's #21 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/4/21. (jss) [Transferred from West Virginia Northern on 4/5/2021.]
|
|
Filing 27
ORDER granting Fidelma L. Fitzpatrick's #19 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/4/21. (jss) [Transferred from West Virginia Northern on 4/5/2021.]
|
| Filing 26 Pro Hac Vice Filing fee for C. Monroe: $ 200.00, receipt number WVNC003108 (jss) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 25 Pro Hac Vice Filing fee for F. Fitzpatrick: $ 200.00, receipt number WVNC003109 (jss) [Transferred from West Virginia Northern on 4/5/2021.] |
|
Filing 24
ORDER granting #18 Frederick M. Erny's Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/2/21. (jss) [Transferred from West Virginia Northern on 4/5/2021.]
|
| Filing 23 Pro Hac Vice Filing fee for F. Erny: $ 200.00, receipt number WVNE016239 (jss) [Transferred from West Virginia Northern on 4/5/2021.] |
|
Filing 22
PAPERLESS ORDER: For reasons appearing to the Court, the scheduling conference, currently scheduled for Friday, February 12, 2021, is CANCELED. Signed by Senior Judge Irene M. Keeley on 1/29/2021. (cml) [Transferred from West Virginia Northern on 4/5/2021.]
|
| Filing 21 MOTION for Leave to Appear Pro Hac Vice of Chelsea Monroe by Ashley Sigley. (Attachments: #1 Exhibit WV State Bar Fee Receipt, #2 Proposed Order)(Hurst, John) [Transferred from West Virginia Northern on 4/5/2021.] |
|
Filing 20
CONSENT ORDER: ORDER granting #17 Motion for Extension of Time to File Report of Initial Planning Meeting. Signed by Senior Judge Irene M. Keeley on 1/29/21. (jss) Modified on 1/29/2021 to correct spelling error (jss). [Transferred from West Virginia Northern on 4/5/2021.]
|
| Filing 19 MOTION for Leave to Appear Pro Hac Vice of Fidelma Fitzpatrick by Ashley Sigley. (Attachments: #1 Exhibit WV State Bar Fee Receipt, #2 Proposed Order)(Hurst, John) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 18 MOTION for Leave to Appear Pro Hac Vice for Frederick M. Erny by CooperSurgial, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 17 Joint MOTION for Extension of Time to File Report of Initial Planning Meeting by CooperSurgial, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc.. (Attachments: #1 Exhibit 1 and 2, #2 Proposed Order Exhibit 3)(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 16 Corporate Disclosure Statement by Teva Pharmaceuticals, USA, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 15 Corporate Disclosure Statement by Teva Women's Health, LLC. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 14 Corporate Disclosure Statement by CooperSurgial, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 13 Corporate Disclosure Statement by Teva Branded Pharmaceutical Products R&D, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 12 Corporate Disclosure Statement by The Cooper Companies, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 11 ANSWER to #1 Complaint by Teva Branded Pharmaceutical Products R&D, Inc..(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 10 ANSWER to #1 Complaint by CooperSurgial, Inc..(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 9 ANSWER to #1 Complaint by Teva Women's Health, LLC.(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 8 ANSWER to #1 Complaint by Teva Pharmaceuticals, USA, Inc..(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 7 ANSWER to #1 Complaint by The Cooper Companies, Inc..(Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
|
Filing 6
FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 1/15/2021. Rule 26 Meeting Report due by 1/29/2021. Scheduling Conference set for 2/12/2021 02:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 2/22/2021. Signed by Senior Judge Irene M. Keeley on 12/17/2020. (dk) [Transferred from West Virginia Northern on 4/5/2021.]
|
| Filing 5 SUMMONS Returned Executed as to All Parties. (Hurst, John) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 4 STIPULATION to Extend Time to Respond to Complaint by CooperSurgial, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc.. (Wickline, Wm.) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 3 NOTICE of Appearance by James P. McHugh on behalf of CooperSurgial, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. (McHugh, James) [Transferred from West Virginia Northern on 4/5/2021.] |
| Filing 1 COMPLAINT against All Defendants filed by Ashley Sigley. Filing Fee $400 - Receipt #0424-3155214 (Attachments: #1 Civil Cover Sheet)(jss) [Transferred from West Virginia Northern on 4/5/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
